Stuart Cable > Goodwin > San Francisco, United States > Lawyer Profile
Goodwin Offices
THREE EMBARCADERO CENTER
SAN FRANCISCO, CA 94111
CALIFORNIA
United States
- Firm Profile
- Go to...
Stuart Cable
Position
Partner / Vice Chairman Goodwin / Global Chair M&A
Career
Stuart Cable is a trusted advisor to a number of world’s most innovative technology and life sciences companies. From emerging startups to established global brands in the technology and life sciences sectors, Stuart’s visionary leadership, business acumen and unparalleled experience allows him to navigate the increasingly rapid pace of change and serve the varied needs of the innovators shaping the future.
Stuart’s boundless commitment to innovation has also made him the driving force behind a number of the firm’s pioneering programs, initiatives and partnerships. Most recently, Stuart’s co-founded with his partner, Lisa Haddad, GOOD Directors, a first-of-its-kind national leadership program designed to create opportunities for next-generation, BIPOC, LGBTQ+ and women leaders to join Boards of Directors of public companies. He also founded Goodwin’s Directors Forum, the firm’s annual forum designed specifically for the directors of the leading public companies, and Goodwin Labs, a pro bono program supporting life sciences startup incubators.
Education
JD, 1979, Columbia Law School (Harlan Fiske Stone Scholar) / MBA, 1976, Tuck School of Business at Dartmouth / AB, 1975, Dartmouth College (magna cum laude)
Lawyer Rankings
United States > M&A/corporate and commercial > M&A: middle-market ($500m-999m)
(Leading lawyers)Able to call upon a network of intellectual property, real estate and tax experts, Goodwin is best known for its strong track record in complex M&A involving life sciences, tech, and private equity players. The department is well positioned to handle public and private M&A, leveraged buyouts, and spin-offs, and is also skilled in shareholder activism defense and proxy contests. Based in Boston, Stuart Cable spearheads the global M&A practice. Cable is counsel of choice for a number of leading tech and life sciences clients, who retain him on a recurrent basis in transactional and corporate governance matters. On the West Coast, Alessandra Simons is a prominent M&A figure in San Francisco, while Andrew Weidhaas in Los Angeles focuses on private equity deals and emerging companies.
United States > Healthcare > Life sciences
Goodwin’s life sciences team assist a diverse roster of pharmaceutical companies – both public and private – and life science venture capital firms. Mitchell Bloom and Kingsley Taft jointly lead the team; Taft primarily advises life sciences companies throughout their life cycles on formation, venture financings, and IPOs, while Bloom is active in the biotechnology and medical IT spaces. Boston-based Robert Puopolo maintains a transactions focused practice, handling joint ventures and life sciences M&A. In San Francisco, Alexander Varond takes the lead on litigious matters concerning biosimilars and the Hatch-Waxman Act. Stuart Cable is particularly adept at advising on corporate governance and venture sourced investment, while Danielle Lauzon assists boards and management teams of therapeutics and bioscience companies. A large team including Philadelphia-based Rachael Bushey, who specializes in transactional and governance work in the pharma and biotech space, joined the firm from Troutman Pepper in January 2023. All named practitioners are based in Boston unless specified otherwise.
Lawyer Rankings
- Leading lawyers United States > M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Life sciences United States > Healthcare
- M&A: middle-market ($500m-999m) United States > M&A/corporate and commercial
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)